The Impact of Inflammation-Induced Tumor Plasticity during Myeloid Transformation

Anna Yeaton, Geraldine Cayanan, Sanam Loghavi, Igor Dolgalev, Emmett M. Leddin, Christian E. Loo, Hedieh Torabifard, Deedra Nicolet, Jingjing Wang, Kate Corrigan, Varvara Paraskevopoulou, Daniel T. Starczynowski, Eric Wang, Omar Abdel-Wahab, Aaron D. Viny, Richard M. Stone, John C. Byrd, Olga A. Guryanova, Rahul M. Kohli, G. Andrés CisnerosAristotelis Tsirigos, Ann Kathrin Eisfeld, Iannis Aifantis, Maria Guillamot

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Abstract

Clonal hematopoiesis (CH) is an aging-associated condition characterized by the clonal outgrowth of mutated preleukemic cells. Individuals with CH are at an increased risk of developing hematopoietic malignancies. Here, we describe a novel animal model carry-ing a recurrent TET2 missense mutation frequently found in patients with CH and leukemia. In a fashion similar to CH, animals show signs of disease late in life when they develop a wide range of myeloid neoplasms, including acute myeloid leukemia (AML). Using single-cell transcriptomic profiling of the bone marrow, we show that disease progression in aged animals correlates with an enhanced inflammatory response and the emergence of an aberrant inflammatory monocytic cell population. The gene signature characteristic of this inflammatory population is associated with poor prognosis in patients with AML. Our study illustrates an example of collaboration between a genetic lesion found in CH and inflammation, leading to transformation and the establishment of blood neoplasms.

Original languageEnglish (US)
Pages (from-to)2392-2413
Number of pages22
JournalCancer discovery
Volume12
Issue number10
DOIs
StatePublished - Oct 1 2022

ASJC Scopus subject areas

  • Oncology

Fingerprint

Dive into the research topics of 'The Impact of Inflammation-Induced Tumor Plasticity during Myeloid Transformation'. Together they form a unique fingerprint.

Cite this